Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2026 11:27 ET | Source: Research and Markets

Healthcare Analytics Research Report 2026: A $181.34 Billion Market by 2031, Driven by Cost Optimization Pressures, Population Health Investments and Expanding Use of Cognitive Analytics Platforms

Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "Healthcare Analytics Market" report has been added to ResearchAndMarkets.com's offering. In 2024, the market is valued at approximately USD 50.01...
May 12, 2026 09:30 ET | Source: Agios Pharmaceuticals, Inc.

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Agios announces new data on mitapivat will be featured in oral and poster presentations at EHA 2026 in Stockholm, Sweden, June 11-14, 2026
May 12, 2026 09:00 ET | Source: Robin Energy Ltd.

Robin Energy Ltd. Reports Results for the Three Months Ended March 31, 2026

LIMASSOL, Cyprus, May 12, 2026 (GLOBE NEWSWIRE) -- Robin Energy Ltd. (NASDAQ: RBNE), (“Robin”, or the “Company”), an international ship-owning company providing energy transportation services...
May 12, 2026 09:00 ET | Source: MarketNewsUpdates.com

Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary -- Investor interest in the next-generation wellness market is picking up fast as peptide-based health and performance...
May 12, 2026 08:50 ET | Source: Fluence

Fluence Announces Secondary Offering of Class A Common Stock by Existing Controlling Stockholders

ARLINGTON, Va., May 12, 2026 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a global market leader delivering intelligent energy storage, operational services, and asset...
May 12, 2026 08:41 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder

Vancouver, Canada, May 12, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development...
May 12, 2026 08:31 ET | Source: 20/20 Biolabs Inc.

20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina

20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina
May 12, 2026 08:30 ET | Source: SureNano Science Ltd.

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include paid advertising. NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- SureNano Science Ltd. (CSE:...
May 12, 2026 08:30 ET | Source: PodcastOne

PodcastOne (Nasdaq: PODC) Launches Original Podcast It's Okay, We're All Gonna Die and Acquires Life Happens with Barb and Michelle Podcast

LOS ANGELES, May 12, 2026 (GLOBE NEWSWIRE) -- PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, announced today the network launch of It's Okay, We're All Gonna Die with...
May 12, 2026 08:30 ET | Source: MindBio Therapeutics Corp.

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Leveraging AI, Voice Analysis to Develop Intoxication Detection

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- MindBio Therapeutics...